How Investors May Respond To ANI Pharmaceuticals (ANIP) Creating a Retina-Focused FutureVision Advisory Council [Yahoo! Finance]
ANI Pharmaceuticals, Inc. (ANIP)
Last ani pharmaceuticals, inc. earnings: 2/27 08:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
anipharmaceuticals.com/investors_corporate_profile.php
Company Research
Source: Yahoo! Finance
recognized retina and uveitis specialists, to guide the development of its ophthalmology and retina franchise within its Rare Disease business. By enlisting high-profile clinician-researchers across leading U.S. academic and clinical centers, ANI is deepening medical expertise around assets like ILUVIEN and YUTIQ, which could influence how it prioritizes indications, evidence generation, and resource allocation in ophthalmology. Now we'll examine how the FutureVision Advisory Council, and its focus on the retina and uveitis portfolio, interacts with ANI's investment narrative. Find companies with promising cash flow potential yet trading below their fair value To own ANI Pharmaceuticals, you need to believe its Rare Disease and Cortrophin Gel platforms can compound earnings even as generics face tougher comparisons and payer pressure builds. The FutureVision Advisory Council strengthens the retina and uveitis portfolio, but its impact on near term catalysts still looks seconda
Show less
Read more
Impact Snapshot
Event Time:
ANIP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ANIP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ANIP alerts
High impacting ANI Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
ANIP
News
- Implied Volatility Surging for ANI Pharmaceuticals Stock Options [Yahoo! Finance]Yahoo! Finance
- ANI Pharmaceuticals (NASDAQ:ANIP) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $100.00 price target on the stock.MarketBeat
- ANI Pharmaceuticals Announces Formation of “FutureVision Advisory Council” to Help Strategically Guide Ophthalmology and Retina FranchiseGlobeNewswire
- ANI Pharmaceuticals Announces Board TransitionGlobeNewswire
- Does Recent Pipeline News Signal a New Opportunity for ANI Pharmaceuticals Stock in 2025? [Yahoo! Finance]Yahoo! Finance
ANIP
Earnings
- 11/7/25 - Beat
ANIP
Sec Filings
- 12/12/25 - Form 4
- 12/9/25 - Form 4
- 12/9/25 - Form 144
- ANIP's page on the SEC website